Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 2 6Phase 1 4Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 2Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 249Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 114Neoplasms 105Multiple Myeloma 90Neoplasm Metastasis 74Colorectal Neoplasms 73Parkinson Disease 4, Autosomal Dominant Lewy Body 69Lung Neoplasms 64Ovarian Neoplasms 61Leukemia, Myeloid, Acute 50Melanoma 47Carcinoma, Hepatocellular 47Carcinoma, Renal Cell 45Leukemia, Lymphocytic, Chronic, B-Cell 44Triple Negative Breast Neoplasms 42Urinary Bladder Neoplasms 41Stomach Neoplasms 41Squamous Cell Carcinoma of Head and Neck 41Recurrence 40Brain Neoplasms 39Myasthenia Gravis 37Small Cell Lung Carcinoma 34Nasopharyngeal Carcinoma 34Lymphoma, Follicular 34Head and Neck Neoplasms 34Rectal Neoplasms 31Pancreatic Neoplasms 31Lymphoma, Large B-Cell, Diffuse 30Endometrial Neoplasms 29

Interventions

Standard of Care 1Ibuprofen 1Dietary Supplements 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Cachexia × 1 year × Clear all
NCT07356037 2026-01-21

Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
68 enrolled
Gastrointestinal

Cachexia, Carcinoma, Hepatocellular

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed
221 enrolled

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡